AbbVie to Present at Sept. 15 Conference After $10.9B Apogee Deal
AbbVie will participate in the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026, with management delivering a fireside chat at 9:00 a.m. Central time via live audio webcast. The company confirmed it finalized the $10.9 billion acquisition of Apogee Therapeutics, expanding its immunology pipeline. It cited Humira sales declines and reported Phase 3 results for etentamig in relapsed multiple myeloma.